Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

• Published in: Journal of controlled release 2024-01, Vol.365, p.369-383
• Main Authors: Nie, Meifeng, Wu, Shuyu, Chen, Yiyi, Wu, Yangtao, Chen, Ruitong, Liu, Yue, Yue, Mingxi, Jiang, Yao, Qiu, Dekui, Yang, Man, Wang, Zikang, Gao, Jiahua, Xiong, Hualong, Qi, Ruoyao, He, Jinhang, Zhang, Jinlei, Zhang, Liang, Wang, Yingbin, Fang, Mujin, Que, Yuqiong, Yao, Youliang, Li, Shaowei, Zhang, Jun, Zhao, Qinjian, Yuan, Quan, Zhang, Tianying, Xia, Ningshao
• Format: Article
• Language: English
• ISSN: 0168-3659; 1873-4995; 1873-4995
• DOI: 10.1016/j.jconrel.2023.11.025

Micro/Nano-scale particles are widely used as vaccine adjuvants to enhance immune response and improve antigen stability. While aluminum salt is one of the most common adjuvants approved for human use, its immunostimulatory capacity is suboptimal. In this study, we modified risedronate, an immunostimulant and anti-osteoporotic drug, to create zinc salt particle-based risedronate (Zn-RS), also termed particulate risedronate. Compared to soluble risedronate, micronanoparticled Zn-RS adjuvant demonstrated increased recruitment of innate cells, enhanced antigen uptake locally, and a similar antigen depot effect as aluminum salt. Furthermore, Zn-RS adjuvant directly and quickly stimulated immune cells, accelerated the formulation of germinal centers in lymph nodes, and facilitated the rapid production of antibodies. Importantly, Zn-RS adjuvant exhibited superior performance in both young and aged mice, effectively protecting against respiratory diseases such as SARS-CoV-2 challenge. Consequently, particulate risedronate showed great potential as an immune-enhancing vaccine adjuvant, particularly beneficial for vaccines targeting the susceptible elderly.